These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 38853623)

  • 1. Combined peripheral and central ultrasound for the diagnosis of PAH-SSc patients.
    Correale M; Rotondo C; Bevere EML; Tricarico L; Rella V; Villani D; Granato M; Migliozzi C; Cantatore FP; Brunetti ND; Corrado A
    Echocardiography; 2024 Jun; 41(6):e15853. PubMed ID: 38853623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Echocardiographic assessment of regional right ventricular systolic function using two-dimensional strain echocardiography and evaluation of the predictive ability of longitudinal 2D-strain imaging for pulmonary arterial hypertension in systemic sclerosis patients.
    Hekimsoy V; Kaya EB; Akdogan A; Sahiner L; Evranos B; Canpolat U; Aytemir K; Özer N; Tokgozoglu L
    Int J Cardiovasc Imaging; 2018 Jun; 34(6):883-892. PubMed ID: 29322374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Echo Doppler predictors of pulmonary artery hypertension in patients with systemic sclerosis.
    Frea S; Capriolo M; Marra WG; Cannillo M; Fusaro E; Libertucci D; Morello M; Gaita F
    Echocardiography; 2011 Sep; 28(8):860-9. PubMed ID: 21906161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relation of novel echocardiographic measures to invasive hemodynamic assessment in scleroderma-associated pulmonary arterial hypertension.
    Gopal DM; Doldt B; Finch K; Simms RW; Farber HW; Gokce N
    Arthritis Care Res (Hoboken); 2014 Sep; 66(9):1386-94. PubMed ID: 24515598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tricuspid annular plane systolic excursion is a robust outcome measure in systemic sclerosis-associated pulmonary arterial hypertension.
    Mathai SC; Sibley CT; Forfia PR; Mudd JO; Fisher MR; Tedford RJ; Lechtzin N; Boyce D; Hummers LK; Housten T; Zaiman AL; Girgis RE; Hassoun PM
    J Rheumatol; 2011 Nov; 38(11):2410-8. PubMed ID: 21965638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in Right Ventricular Functional Changes during Treatment between Systemic Sclerosis-associated Pulmonary Arterial Hypertension and Idiopathic Pulmonary Arterial Hypertension.
    Argula RG; Karwa A; Lauer A; Gregg D; Silver RM; Feghali-Bostwick C; Schanpp LM; Egbert K; Usher BW; Ramakrishnan V; Hassoun PM; Strange C
    Ann Am Thorac Soc; 2017 May; 14(5):682-689. PubMed ID: 28282243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A right ventricular diastolic impairment is common in systemic sclerosis and is associated with other target-organ damage.
    Meune C; Khanna D; Aboulhosn J; Avouac J; Kahan A; Furst DE; Allanore Y
    Semin Arthritis Rheum; 2016 Feb; 45(4):439-45. PubMed ID: 26272194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The evaluation of right ventricle dyssynchrony by speckle tracking echocardiography in systemic sclerosis patients.
    Demirci M; Ozben B; Sunbul M; Cincin A; Gurel YE; Bayram Guctekin T; Dogan Z; Sahinkaya Y; Direskeneli H; Tigen K; Sayar N
    J Clin Ultrasound; 2021 Nov; 49(9):895-902. PubMed ID: 34259351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased biventricular longitudinal strain in patients with systemic sclerosis is mainly caused by pulmonary hypertension and not by systemic sclerosis per se.
    Lindholm A; Hesselstrand R; Rådegran G; Arheden H; Ostenfeld E
    Clin Physiol Funct Imaging; 2019 May; 39(3):215-225. PubMed ID: 30597705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening for pulmonary arterial hypertension in patients with systemic sclerosis in the era of new pulmonary arterial hypertension definitions.
    Erdogan M; Kilickiran Avci B; Ebren C; Ersoy Y; Ongen Z; Ongen G; Hamuryudan V; Hatemi G
    Clin Exp Rheumatol; 2024 Aug; 42(8):1590-1597. PubMed ID: 38489342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Right ventricular and atrial functions in systemic sclerosis patients without pulmonary hypertension. Speckle-tracking echocardiographic study.
    Durmus E; Sunbul M; Tigen K; Kivrak T; Ozen G; Sari I; Direskeneli H; Basaran Y
    Herz; 2015 Jun; 40(4):709-15. PubMed ID: 24938219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Right Ventricular Myofilament Functional Differences in Humans With Systemic Sclerosis-Associated Versus Idiopathic Pulmonary Arterial Hypertension.
    Hsu S; Kokkonen-Simon KM; Kirk JA; Kolb TM; Damico RL; Mathai SC; Mukherjee M; Shah AA; Wigley FM; Margulies KB; Hassoun PM; Halushka MK; Tedford RJ; Kass DA
    Circulation; 2018 May; 137(22):2360-2370. PubMed ID: 29352073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of the DETECT algorithm for detection of risk of pulmonary arterial hypertension in systemic sclerosis: data from a Czech tertiary centre.
    Soukup T; Pudil R; Kubinova K; Hromadkova L; Dusek J; Tosovsky M; Bradna P; Hrncir Z; Bures J
    Rheumatology (Oxford); 2016 Jan; 55(1):109-14. PubMed ID: 26320140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In systemic sclerosis, the TAPSE/sPAP ratio can be used in addition to the DETECT algorithm for pulmonary arterial hypertension diagnosis.
    Colalillo A; Grimaldi MC; Vaiarello V; Pellicano C; Leodori G; Gigante A; Romaniello A; Rosato E
    Rheumatology (Oxford); 2022 May; 61(6):2450-2456. PubMed ID: 34605890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early detection of pulmonary arterial hypertension in systemic sclerosis: a French nationwide prospective multicenter study.
    Hachulla E; Gressin V; Guillevin L; Carpentier P; Diot E; Sibilia J; Kahan A; Cabane J; Francès C; Launay D; Mouthon L; Allanore Y; Tiev KP; Clerson P; de Groote P; Humbert M
    Arthritis Rheum; 2005 Dec; 52(12):3792-800. PubMed ID: 16320330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study.
    Coghlan JG; Denton CP; Grünig E; Bonderman D; Distler O; Khanna D; Müller-Ladner U; Pope JE; Vonk MC; Doelberg M; Chadha-Boreham H; Heinzl H; Rosenberg DM; McLaughlin VV; Seibold JR;
    Ann Rheum Dis; 2014 Jul; 73(7):1340-9. PubMed ID: 23687283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peripheral microvascular function is linked to cardiac involvement on cardiovascular magnetic resonance in systemic sclerosis-related pulmonary arterial hypertension.
    Vos JL; Lemmers JMJ; El Messaoudi S; Snoeren M; van Dijk APJ; Duijnhouwer AL; Rodwell L; van Leuven SI; Post MC; Vonk MC; Nijveldt R
    Eur Heart J Cardiovasc Imaging; 2024 Apr; 25(5):708-717. PubMed ID: 38170546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of pulmonary arterial stiffness in patients with systemic sclerosis without overt pulmonary hypertension.
    Çoksevim M; Çerik İB; Yenerçağ M; Kocasarı AO; Yavuzbilge G; Polat M; Meriç M; Özgen M
    Int J Cardiovasc Imaging; 2022 Oct; 38(10):2191-2197. PubMed ID: 37726465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment for Pulmonary Artery Hypertension Using Clinical and Echocardiographic Criteria in Patients With Systemic Sclerosis.
    Methia N; Latreche S; Ait Mokhtar O; Monsuez JJ; Benkhedda S
    Am J Med Sci; 2016 Oct; 352(4):343-347. PubMed ID: 27776714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of right ventricular function performed by 3D-echocardiography in scleroderma patients.
    Pigatto E; Peluso D; Zanatta E; Polito P; Miatton P; Bourji K; Badano LP; Punzi L; Cozzi F
    Reumatismo; 2015 Mar; 66(4):259-63. PubMed ID: 25829185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.